Evidence map›Paper›PMID 25939051›Full record

ArticleJournal of visualized experiments : JoVE2015

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling.

Armand O Brown, Carlos J Orihuela

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. New-Onset Atrial Fibrillation as a Sepsis-Defining Organ Failure.Annals of the American Thoracic Society · 2019
    Article
  7. Review
  8. Review
  9. Cell Invasion and Pyruvate Oxidase-Derived HInfection and immunity · 2018
    Article
  10. Increased Zinc Availability Enhances Initial Aggregation and Biofilm Formation ofFrontiers in cellular and infection microbiology · 2017
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Armand O BrownDepartment of Microbiology and Immunology, The University of Texas Health Science Center at San Antonio.
Carlos J OrihuelaDepartment of Microbiology and Immunology, The University of Texas Health Science Center at San Antonio; orihuela@uthscsa.edu.
The University of Texas Health Science Center at San Antonio · US

Funding

Cardiac microlesion formation during invasive pneumococcal diseaseR01AI114800 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Carlos J Orihuela, Herve S TETTELIN · 2015 to 2026
$5.1M
Mechanism of PsrP mediated adhesionR01AI078972 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ORIHUELA, CARLOS J · 2009 to 2013
$1.3M
Statins protect against adverse cardiac events during pneumoniaR21HL108054 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ORIHUELA, CARLOS J · 2011 to 2012
$372k
Pneumococcal Cardiotoxicity During Invasive Pneumococcal DiseaseF31AI104177 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI BROWN, ARMAND · 2014 to 2014
$28k
NHLBI NIH HHS HL108054NHLBI NIH HHS R21 HL108054NIAID NIH HHS AI078972NIAID NIH HHS F31 AI104177NIAID NIH HHS R01 AI078972NIAID NIH HHS R01 AI114800PHS HHS F31 A110417701PHS HHS ULTR001120
6 · The paper itself

Abstract

During bacteremia Streptococcus pneumoniae can translocate across the vascular endothelium into the myocardium and form discrete bacteria-filled microscopic lesions (microlesions) that are remarkable due to the absence of infiltrating immune cells. Due to their release of cardiotoxic products, S. pneumoniae within microlesions are thought to contribute to the heart failure that is frequently observed during fulminate invasive pneumococcal disease in adults. Herein is demonstrated a protocol for experimental mouse infection that leads to reproducible cardiac microlesion formation within 30 hr. Instruction is provided on microlesion identification in hematoxylin & eosin stained heart sections and the morphological distinctions between early and late microlesions are highlighted. Instruction is provided on a protocol for verification of S. pneumoniae within microlesions using antibodies against pneumococcal capsular polysaccharide and immunofluorescent microscopy. Last, a protocol for antibiotic intervention that rescues infected mice and for the detection and assessment of scar formation in the hearts of convalescent mice is provided. Together, these protocols will facilitate the investigation of the molecular mechanisms underlying pneumococcal cardiac invasion, cardiomyocyte death, cardiac remodeling as a result of exposure to S. pneumoniae, and the immune response to the pneumococci in the heart.

Indexed as

Disease Models, AnimalAnimalsAnti-Bacterial AgentsEndothelium, VascularHeart DiseasesMicePneumococcal InfectionsStreptococcus pneumoniaeAnti-Bacterial Agents

Identifiers

PMID25939051
PMCPMC4541479
OpenAlexW2093835116

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.